These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 28655548)
1. Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure. Andrade DV; Harris E Virus Res; 2018 Aug; 254():27-33. PubMed ID: 28655548 [TBL] [Abstract][Full Text] [Related]
2. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections. Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731 [TBL] [Abstract][Full Text] [Related]
3. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():597. PubMed ID: 29740424 [TBL] [Abstract][Full Text] [Related]
4. Human antibody response to Zika targets type-specific quaternary structure epitopes. Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133 [TBL] [Abstract][Full Text] [Related]
5. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Priyamvada L; Hudson W; Ahmed R; Wrammert J Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557 [TBL] [Abstract][Full Text] [Related]
6. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus. Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS mBio; 2016 Jul; 7(4):. PubMed ID: 27435464 [TBL] [Abstract][Full Text] [Related]
10. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa. Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308 [TBL] [Abstract][Full Text] [Related]
11. Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity. Priyamvada L; Suthar MS; Ahmed R; Wrammert J J Infect Dis; 2017 Dec; 216(suppl_10):S906-S911. PubMed ID: 29267924 [TBL] [Abstract][Full Text] [Related]
12. A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease? Sariol CA; Nogueira ML; Vasilakis N Trends Microbiol; 2018 Mar; 26(3):186-190. PubMed ID: 29122447 [TBL] [Abstract][Full Text] [Related]
13. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections. Andrade P; Coloma J; Harris E Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181 [TBL] [Abstract][Full Text] [Related]
17. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091 [TBL] [Abstract][Full Text] [Related]